Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2459 Target Snapshot

Peroxisome proliferator-activated receptor gamma · SINGLE PROTEIN · Mus musculus

448Compounds
259Assays
5Approved Drugs
287.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P37238. Use UniProt P37238 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P37238 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Peroxisome proliferator-activated receptor gamma as ChEMBL target CHEMBL2459, mapped to UniProt P37238. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Peroxisome proliferator-activated receptor gamma
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL2459
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P37238
Peroxisome proliferator-activated receptor gamma
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Peroxisome proliferator-activated receptor gamma is the right protein anchor across sources, using UniProt P37238 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPeroxisome proliferator-activated receptor gamma
UniProt AccessionP37238
Component TypeProtein
Sequence Length505 aa

Peroxisome proliferator-activated receptor gamma

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Peroxisome proliferator-activated receptor gamma, mapped to UniProt P37238. Sequence length is 505 aa.

Mapped IDP37238
Review namePeroxisome proliferator-activated receptor gamma
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

5
Approved
4
Phase III
8
Phase II
Assay Mix

Activity Type Distribution

IC5015.0
KI1.0
EC50271.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5207130 9.85 IC50 0.14 Preclinical
CHEMBL107367 9.46 EC50 0.35 Clinical
CHEMBL106666 8.92 EC50 1.2 Preclinical
CHEMBL602468 8.7 EC50 2.0 Preclinical
CHEMBL3115237 8.52 EC50 3.0 Preclinical
CHEMBL5288454 8.39 EC50 4.1 Preclinical
CHEMBL423026 8.33 EC50 4.677 Preclinical
CHEMBL5267263 8.06 IC50 8.7 Preclinical
CHEMBL3115238 8.05 EC50 9.0 Preclinical
CHEMBL278994 8.0 EC50 10.0 Preclinical
Distribution

pChEMBL Value Distribution

27
5.0
36
5.5
65
6.0
51
6.5
26
7.0
17
7.5
5
8.0
3
8.5
2
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

ROSIGLITAZONE
CHEMBL121
Approved 1999
PIOGLITAZONE
CHEMBL595
Approved 1999
TROGLITAZONE
CHEMBL408
Approved 1997
Assay Landscape

Assay Landscape

259
Total Assays
163
Tested Compounds
4
Assay Types
Binding — 202 assays, 74 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 175 62 6.4
single protein format 16 12 6.2
organism-based format 7 0
assay format 4 0
Functional — 40 assays, 163 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 25 137 6.4
assay format 9 26 6.5
organism-based format 6 0
ADME — 14 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 14 0
Toxicity — 3 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine